Cancer Family

Lymphocytic Neoplasm

HematologicNon-malignant3,036 active trials72 approved drugs345 evidence items

NCIt: C7065

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (380)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 126–150 of 380 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Optimising survivorship care in Hodgkin's lymphoma: Aligning practice with Ireland's AYA cancer framework.
Maeve Kearney, Sara Faithfull, Michelle Leech · J Cancer Policy · Sep 1, 2026 · PMID 42520965 · candidate dictionary pubmed
Survival by Race and Ethnicity in Children and Adolescents/Young Adults With Relapsed/Refractory Hodgkin Lymphoma: A Pooled Analysis of Children's Oncology Group Trials.
Mallorie B Heneghan, Lindsay A Renfro, Yue Wu et al. · Pediatr Blood Cancer · Sep 1, 2026 · PMID 42496647 · candidate dictionary pubmed
Primary Pulmonary Hodgkin Lymphoma: A Cytologic Diagnostic Challenge.
Nicholas Jin Hong Tan, Vanda F Torous · Diagn Cytopathol · Sep 1, 2026 · PMID 42415350 · candidate dictionary pubmed
Phase I study of glofitamab in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
Yuko Shirouchi, Yuko Mishima, Suguru Fukuhara et al. · Int J Clin Oncol · Sep 1, 2026 · PMID 42390726 · candidate dictionary pubmed
Role of radiotherapy in refractory/relapsed classical Hodgkin lymphoma in the era of targeted therapies and immunotherapy.
Sukeina Baouia, Rafik Nebbache, Côme Bommier et al. · Clin Transl Radiat Oncol · Sep 1, 2026 · PMID 42388465 · candidate dictionary pubmed
PD-1/PD-L1 immune checkpoint inhibitors in Hodgkin lymphoma: A meta- and network meta-analysis.
Tingxi Zhu, Zhongyu Liu, Huan Sun et al. · Transl Oncol · Sep 1, 2026 · PMID 42349316 · candidate dictionary pubmed

Primary Classical Hodgkin Lymphoma of the Urinary Bladder: Expanding the Spectrum of Bladder Lymphoid Neoplasms.

Sinem Eser Polat Ünal, Dinç Süren, Erdal Kurtoğlu · Int J Surg Pathol · Sep 1, 2026 · PMID 41917790 · candidate dictionary pubmed

[Diagnosis of classic Hodgkin lymphoma and its imitators].

Steffen Gretser, Ilske Oschlies, Karoline Koch et al. · Pathologie (Heidelb) · Sep 1, 2026 · PMID 42008185 · candidate dictionary pubmed

A U-Shaped Association: The First-Year eGFR Slope and Mortality Risk in Multiple Myeloma.

Lian Li, Xiang Liu, Mingjing Guan et al. · Cancer Med · Sep 1, 2026 · PMID 42702740 · candidate dictionary pubmed

Construction and Validation of a Progression-Free Survival Prediction Model for Newly Diagnosed Multiple Myeloma Patients With 1q21 Gain/Amplification.

Yuexuan Rao, Shiyou Li, Aoyang Yu et al. · Cancer Med · Sep 1, 2026 · PMID 42701330 · candidate dictionary pubmed

Sparse integrative dictionary learning resolves conserved drug-response states in multiple myeloma (MM).

Mingke Wu, Jin Lu, Qing Ge · Cancer Genet · Sep 1, 2026 · PMID 42600555 · candidate dictionary pubmed

Clonal Hematopoiesis in Newly Diagnosed Multiple Myeloma: Associations With Neutropenia, Supportive Care Burden, and Survival.

Ahmet Yigitbasi, Fulya Oz Puyan, Hakki Onur Kirkizlar et al. · Clin Lymphoma Myeloma Leuk · Sep 1, 2026 · PMID 42567754 · candidate dictionary pubmed

Early Serum Free Light Chain Response in Newly Diagnosed Multiple Myeloma: Documented Earlier Than MRD and Complementary in Prognosis.

Yubiao Pan, Yue Wang, Yaqin Xiong et al. · Hematol Oncol · Sep 1, 2026 · PMID 42549699 · candidate dictionary pubmed

Pre-CAR-HEMATOTOX at Leukapheresis Predicts Delayed Platelet Recovery After Idecabtagene Vicleucel in Multiple Myeloma.

Taku Kikuchi, Moe Nomura-Yogo, Ukyo Kondo et al. · Clin Lymphoma Myeloma Leuk · Sep 1, 2026 · PMID 42542408 · candidate dictionary pubmed

Belantamab Mafodotin for Patients With Multiple Myeloma: Clinical Development and Practical Strategies for Dose Optimization and Toxicity Management.

Roberto Mina, Evangelos Terpos, Lorenzo Cani et al. · Clin Lymphoma Myeloma Leuk · Sep 1, 2026 · PMID 42521571 · candidate dictionary pubmed

Dual bispecific protein engager-armed T cells targeting BCMA and B7-H3 overcome antigen heterogeneity in multiple myeloma.

Thanida Chanpong, Nunghathai Sawasdee, Kamonlapat Supimon et al. · Biomed Pharmacother · Sep 1, 2026 · PMID 42497585 · candidate dictionary pubmed

Knowledge, Awareness, and Practice Patterns of Nephrologists in the Diagnosis and Management of Multiple Myeloma (MIND-MM Study): A Cross-Sectional, Web-Based, CHERRIES-Compliant Survey with Position Statement from the Indian Myeloma Academic Groupe (IMAGe) and Indian Society of Nephrology (ISN).

Uday Yanamandra, Raja Ramachandran, Vinay Sakhuja et al. · Clin Lymphoma Myeloma Leuk · Sep 1, 2026 · PMID 42471300 · candidate dictionary pubmed

Triptonide enhances DNA damage by inhibiting TRIP13‑mediated DNA repair and synergizes with bortezomib to suppress multiple myeloma.

Fen He, Junjun Li, Lijun Peng et al. · Int J Oncol · Sep 1, 2026 · PMID 42464653 · candidate dictionary pubmed

Kidney Transplantation Post-Chimeric Antigen Receptor (CAR) T-Cell Therapy in Multiple Myeloma.

Zahraa Khan, Darshana M Dadhania, Eugene Brailovski et al. · Am J Kidney Dis · Sep 1, 2026 · PMID 42379467 · candidate dictionary pubmed

Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma.

Kenneth J C Lim, Shaji Kumar, Ricardo Parrondo et al. · Am J Hematol · Sep 1, 2026 · PMID 42351384 · candidate dictionary pubmed

NHE6-driven endosome-autophagy axis confers proteasome inhibitor resistance in multiple myeloma.

Liuting Chen, Feifei Cheng, Yung-Hsing Huang et al. · Drug Resist Updat · Sep 1, 2026 · PMID 42349083 · candidate dictionary pubmed

Cost-Effectiveness of Autologous Stem Cell Transplantation in Multiple Myeloma Patients Aged 65 to 69 Years (CAREMM-2110 Study).

Jung Yeon Lee, Seungpil Jung, Sung-Soo Park et al. · Value Health · Sep 1, 2026 · PMID 42331283 · candidate dictionary pubmed

The Changing Landscape of Maintenance Therapy in Newly Diagnosed Multiple Myeloma: A Systematic Review With Network Meta-Analysis of the European Myeloma Network (EMN).

Heinz Ludwig, Evangelos Terpos, Francesca Gay et al. · Am J Hematol · Sep 1, 2026 · PMID 42315477 · candidate dictionary pubmed

Calpain-2 inhibition alleviates hypercalcemia-driven multiple myeloma progression.

Zeyuan Wang, Chaoying Yang, Yanpeng Wang et al. · Biochem Pharmacol · Sep 1, 2026 · PMID 42315074 · candidate dictionary pubmed

Patient-Centric First-in-Human Dose Selection: An Ex Vivo Minimal Anticipated Biological Effect Level Approach for T-Cell Engagers in Multiple Myeloma.

Thomas E Kraft, Estelle Marrer-Berger, Sara Belli et al. · Clin Pharmacol Ther · Sep 1, 2026 · PMID 42310437 · candidate dictionary pubmed